Strategic Partnerships Agena Bioscience has a track record of partnerships and collaborations with organizations like Precision for Medicine and Manchester University, indicating strong sell-in potential for co-development, distribution, or joint research programs in pharmacogenomics and targeted panels.

Genetic Panel Expansion The recent launch of a broader genetic testing panel for cystic fibrosis demonstrates a willingness to expand product capabilities; sales teams can target labs requiring expanded mutation detection and companion diagnostics in related genetic disease areas.

MassARRAY Platform Agena’s MassARRAY system is an open, highly multiplexed platform suitable for diverse targeted analyses; opportunity to upsell additional assays, consumables, and software integrations to existing MassARRAY customers across biotech and academic labs.

Global Reach Headquartered in San Diego with international offices and prior global distribution partnerships, there is appetite for expanding into new emerging markets through distributors or direct regional teams, increasing addressable market and volume opportunities.

Affiliations and Funding Signals Previous acquisition activity and strategic press indicates capacity for scale and integration; use this to position value in long-term collaborations, licensing, or OEM opportunities with larger players seeking targeted genomic solutions.